(PRWEB) April 8, 2005

Immunotherapy is allergy shots which are usually reserved for people who have more severe symptoms of sinusitis, sinus infection and allergy. This can be time consuming and expensive however, shots will decrease you risk of developing asthma and other related reactions.

Sinus pressure infection is just one of the symptoms. This is due to irritation in the nose by irritants with the big chance that sinuses may become irritated and therefore cause the swelling of the sinus membranes.

Studies shows that immunotherapy injections like desensitization and allergy shots can improve symptom severity and reduce medication use and may even reduce the risk of developing new allergies and sinus infections in the future.

Recent human studies using fragments of DNA attached to allergen offer the prospect of stimulating a potent anti-allergic immune response without the risk of allergic reactions. such methods offer the possibility of developing preventative allergy “vaccines” that might prevent the onset of disease if administered to children at high risk. From time to time, studies describing more convenient and less frequent treatments have been described.

The American Academy of Allergy, Asthma and Immunology (AAAAI) has this objective of allergen immunotherapy to improve the practice of allergen immunotherapy for patients with allergic rhinitis, allergic asthma, sinusitis and sinus infections.

This stricture is intended to increase the appropriate use of allergen immunotherapy, reduce the under use, overuse and misuse of allergen immunotherapy; and simply establish guidelines for the safe and effective use of allergen immunotherapy, while reducing unwanted and unneeded variation in immunotherapy practice.

About Sinusinfectionproblems.com

Sinusinfectionproblems.com is an online help for those persons who are suffering sinus infection problems. This site can give you a better understanding about sinus pressures that a certain person can have when he has serious sinus infection.

LONDON (Reuters) – the severity of Parkinson's disease symptoms could be monitored remotely by analyzing speech patterns, saving health authorities time and money and easing the burden on patients, scientists said Wednesday.

Researchers from Britain and the United States analyzed almost 6,000 speech recordings from 42 people with Parkinson's and developed algorithms using the data to estimate how bad the symptoms were.

The results, published in the Royal Society's journal Interface, showed the algorithms were close to assessments made by doctors.

"Currently, monitoring requires frequent visits to hospital where people with Parkinson's are physically examined by expert clinicians in order to assess their symptom severity, putting a strain on both patients and hospital resources," said Max little of Britain's Oxford University, who worked on the study.

The researchers said they believed the technique, which could be used with patients' speech recordings or over the telephone, could help ease the resource burden on health systems and make it possible to run large-scale trials of experimental treatments for Parkinson's.

Parkinson's is a fatal and incurable brain disease that affects between 1 percent and 2 percent of people over the age of 65. it often affects the patient's ability to speak clearly, and sufferers also have tremors, sluggish movement, muscle stiffness and difficulty with balance.

Little said the study provided good evidence that speech impairment and the average overall severity of other Parkinson's disease symptoms are very closely linked, suggesting that symptom severity can be measured just by analyzing speech.

"this sort of remote monitoring — or 'telemonitoring' — of people's health is particularly important for people with Parkinson's who may find it difficult to make frequent hospital visits," he said in statement.

"the hope is that our research could pave the way for very large clinical studies of new treatments for Parkinson's where the sort of frequent monitoring required would not otherwise be affordable."

The researchers compared estimates made using the new technique with assessments made by doctors and rated on a standard measure for Parkinson's severity called the Unified Parkinson's Disease Rating Scale (UPDRS).

They found that, based on around 140 speech samples from each of the 42 patients, the estimates made using the algorithms differed from doctors' UPDRS ratings by around 2 points.

(Reporting by Kate Kelland, editing by Andrew Dobbie)